[Thyrotropin level and its reaction to thyroliberin in vibration pathology].
The article shows that radioimmunoassay detection of thyrotropin in human blood serum against the introduction of synthetic hypothalamic thyrotropin releasing hormone, helps to specify vibration disease induced regulatory disorders in the hypothalamus--pituitary body system. Pituitary body thyrotropin secretion activation with concomitant thyroliberin induced decrease of thyrotropin indicates the limited adaptation within the system, and, either results from compensatory adaptative processes in the organism, or marks the initial stage of functional disorder.
Shpigel'
A S
AS
D000222:Adaptation, Physiological; D003864:Depression, Chemical; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000209:etiology / Q000503:physiopathology*; D010901:Pituitary Function Tests; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D013268:Stimulation, Chemical; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone; D014732:Vibration / Q000009:adverse effects*
D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin
Soderzhanie tirotropina i ego reaktsiia na tiroliberin pri vibratsionnoĭ patologii.